Fiasp FlexTouch (3ml Each) contains Insulin Aspart (100IU/ml), a rapid-acting insulin analog designed to improve blood sugar control in individuals with diabetes mellitus. This medication works by mimicking the natural insulin produced by the pancreas, facilitating the uptake of glucose into cells for energy production and reducing elevated blood glucose levels. Fiasp FlexTouch is specifically formulated for subcutaneous injection and is intended for use shortly before or immediately after meals to manage postprandial blood sugar spikes effectively. The FlexTouch pen device offers ease of use with a prefilled, disposable design that allows for precise dosing and convenient administration, enhancing patient adherence to insulin therapy. It is suitable for adults and children with type 1 or type 2 diabetes who require rapid-acting insulin to achieve optimal glycemic control. Patients should monitor their blood glucose regularly and follow their healthcare provider’s instructions regarding dosage and timing to minimize the risk of hypoglycemia. Fiasp FlexTouch should be stored in a refrigerator before use and kept at room temperature once in use, with careful attention to expiration dates. Always consult a healthcare professional before initiating or adjusting insulin therapy.